DelMar Pharmaceuticals Inc buy melinda
Start price
26.04.17
/
50%
?24.71
Target price
26.10.17
€36.08
Performance (%)
-68.72%
End price
26.10.17
€7.73
Summary
This prediction ended on 26.10.17 with a price of €7.73. The BUY prediction by melinda for DelMar Pharmaceuticals Inc performed very badly with a performance of -68.72%. melinda has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| DelMar Pharmaceuticals Inc | - | - | - | - |
| iShares Core DAX® | -0.922% | -1.993% | 13.399% | 16.075% |
| iShares Nasdaq 100 | 0.371% | -0.868% | 41.541% | 46.938% |
| iShares Nikkei 225® | 2.224% | -5.187% | 20.497% | 4.643% |
| iShares S&P 500 | -0.026% | -0.918% | 30.410% | 42.418% |
Comments by melinda for this prediction
In the thread DelMar Pharmaceuticals Inc diskutieren
Forschung Entwicklung
DelMar Pharmaceuticals, Inc. ist ein in der klinischen Arzneimittelentwicklung und Handelsgesellschaft, die für die Behandlung von cancer.It bietet VAL-083 auf die Forschung und Entwicklung von Arzneimitteln konzentriert; die Suche nach der Wirkstoffforschung; sowie Firmeneigentum und Patente
(Laufzeit überschritten)
Stopped prediction by melinda for DelMar Pharmaceuticals Inc
DelMar Pharmaceuticals Inc
Start price
Target price
Perf. (%)
?3.71
19.01.19
19.01.19
€4.69
20.03.19
20.03.19
28.19%
20.03.19
20.03.19
DelMar Pharmaceuticals Inc
Start price
Target price
Perf. (%)
?10.28
21.11.17
21.11.17
€18.04
20.12.17
20.12.17
-28.07%
20.12.17
20.12.17
DelMar Pharmaceuticals Inc
Start price
Target price
Perf. (%)
?11.40
21.11.17
21.11.17
€20.00
20.12.17
20.12.17
-28.07%
20.12.17
20.12.17